Albany,NY (PRWEB) August 05, 2014
Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide.
Title: Companion Diagnostics Market
Published: 29 Aug 2013
Price: US$ 4,595.00 (Single User)
For further inquiries, click here: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=387.
Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers. Pharmaceutical companies are either focusing on in-house development of companion diagnostics or develo
Copyright©2014 Vocus, Inc.
All rights reserved